Signaling pathways of chronic kidney diseases, implications for therapeutics
Q Yuan, B Tang, C Zhang - Signal transduction and targeted therapy, 2022 - nature.com
Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …
Adiponectin, leptin and cardiovascular disorders
S Zhao, CM Kusminski, PE Scherer - Circulation research, 2021 - Am Heart Assoc
The landmark discoveries of leptin and adiponectin firmly established adipose tissue as a
sophisticated and highly active endocrine organ, opening a new era of investigating adipose …
sophisticated and highly active endocrine organ, opening a new era of investigating adipose …
Adipogenesis and metabolic health
AL Ghaben, PE Scherer - Nature reviews Molecular cell biology, 2019 - nature.com
Obesity is characterized by increased adipose tissue mass and has been associated with a
strong predisposition towards metabolic diseases and cancer. Thus, it constitutes a public …
strong predisposition towards metabolic diseases and cancer. Thus, it constitutes a public …
Obesity, kidney dysfunction and hypertension: mechanistic links
JE Hall, JM do Carmo, AA da Silva, Z Wang… - Nature reviews …, 2019 - nature.com
Excessive adiposity raises blood pressure and accounts for 65–75% of primary
hypertension, which is a major driver of cardiovascular and kidney diseases. In obesity …
hypertension, which is a major driver of cardiovascular and kidney diseases. In obesity …
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Obesity, diabetes mellitus, hypertension and cardiovascular disease are risk factors for
chronic kidney disease (CKD) and kidney failure. Chronic, low-grade inflammation is …
chronic kidney disease (CKD) and kidney failure. Chronic, low-grade inflammation is …
Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the American Heart Association
Hypertension is a major risk factor for cardiovascular and renal diseases in the United States
and worldwide. Obesity accounts for much of the risk for primary hypertension through …
and worldwide. Obesity accounts for much of the risk for primary hypertension through …
Obesity and inflammation
J Karczewski, E Śledzińska, A Baturo, I Jończyk… - European cytokine …, 2018 - Springer
The prevalence of obesity has recently increased dramatically and has contributed to the
increasing prevalence of various pathological conditions, including type 2 diabetes mellitus …
increasing prevalence of various pathological conditions, including type 2 diabetes mellitus …
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
JE Hall, AJ Mouton, AA da Silva… - Cardiovascular …, 2021 - academic.oup.com
Abstract Obesity contributes 65–75% of the risk for human primary (essential) hypertension
(HT) which is a major driver of cardiovascular and kidney diseases. Kidney dysfunction …
(HT) which is a major driver of cardiovascular and kidney diseases. Kidney dysfunction …
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
G Xourafa, M Korbmacher, M Roden - Nature Reviews Endocrinology, 2024 - nature.com
Type 2 diabetes mellitus (T2DM) is characterized by tissue-specific insulin resistance and
pancreatic β-cell dysfunction, which result from the interplay of local abnormalities within …
pancreatic β-cell dysfunction, which result from the interplay of local abnormalities within …
[HTML][HTML] Adipocyte mesenchymal transition contributes to mammary tumor progression
Obesity is associated with increased cancer incidence and progression. However, the
relationship between adiposity and cancer remains poorly understood at the mechanistic …
relationship between adiposity and cancer remains poorly understood at the mechanistic …